GlobalData on MSN
Pharma eyes AI deals to stem lost revenues from patent expirations
Drug developers integrate AI capabilities as a potentially transformative strategy to combat patent cliff losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results